Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin

References

• Clark SC. Lung injury after cardiopulmonary bypass. Perfusion 2006;21:225–8.
   PubMed Web of Science ®Google Scholar
• Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, Meliones JN, Cheifetz IM, Jaggers JJ, Ungerleider RM. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thor Surg 1999;67:731–5.
   PubMed Web of Science ®Google Scholar
• Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyerdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thor Cardiovasc Surg 2002;123:1199–205.
   PubMed Web of Science ®Google Scholar
• Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:806–11.
   PubMed Web of Science ®Google Scholar
• Carter J, Buerke U, Rössner E, Russ M, Schubert S, Schmidt H, Ebelt H, Pruefer D, Schlitt A, Werdan K, Buerke M. Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury. Br J Pharmacol 2008;155:93–102.
   PubMed Web of Science ®Google Scholar
• Asimakopoulos G, Lidington EA, Mason J, Haskard DO, Taylor KM, Landis RC. Effect of aprotinin on endothelial cell activation. J Thorac Cardiovasc Surg 2001;122:123–8.
   PubMed Web of Science ®Google Scholar
• Harmon D, Ghori K, Lan W, Shorten G. Effect of aprotinin on in vitro cerebral endothelial ICAM-1 expression induced by astrocyte-conditioned medium. Eur J Anaesthesiol 2005;22:277–82.
   PubMed Web of Science ®Google Scholar
• Lazar HL, Bao Y, Tanzillo L, O’Gara P, Reardon D, Price D, Crowley R, Cabral HJ. Aprotinin decreases ischemic damage during coronary revascularization. J Card Surg 2005;20:519–23.
   PubMed Web of Science ®Google Scholar
• Yun TJ1, Rho JR. Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary bypass. J Korean Med Sci 2006;21:25–9.
   PubMed Web of Science ®Google Scholar
• Eren S, Esme H, Balci AE, Cakir O, Buyukbayram H, Eren MN, Erdinc L, Satici O. The effect of aprotinin on ischemia-reperfusion injury in an in situ normothermic ischemic lung model. Eur J Cardiothorac Surg 2003;23:60–5.
   PubMed Web of Science ®Google Scholar
• Mathias MA1, Tribble CG, Dietz JF, Nguyen RP, Shockey KS, Kern JA, Kron IL. Aprotinin improves pulmonary function during reperfusion in an isolated lung model. Ann Thorac Surg 2000;70:1671–4.
   PubMed Web of Science ®Google Scholar
• Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J; Investigators of The Multicenter Study of Perioperative Ischemia Research Group.; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;7:471–9.
   Web of Science ®Google Scholar
• Lamarche Y, Gagnon J, Malo O, Blaise G, Carrier M, Perrault LP. Ventilation prevents pulmonary endothelial dysfunction and improves oxygenation after cardiopulmonary bypass without aortic cross-clamping. Eur J Cardiothorac Surg 2004;26:554–63.
   PubMed Web of Science ®Google Scholar
• Gagnon J, Laporta D, Beique F, Langlois Y, Morin J-F. Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction. Perfusion 2010;24:205–10.
   Web of Science ®Google Scholar
• Törnberg DC, Angdin M, Settergen G, Liska J, Lundberg JO, Weitzberg E. Exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass-response to acetylcholine and nitroglycerin. Br J Anaesth 2005;94:174–80.
   PubMed Web of Science ®Google Scholar
• Toikkanen V, Rinne T, Huhtala H, Laurikka J, Porkkala H, Tarkka M, Mennander A. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery. Scand J Clin Lab Invest 2014;74:37–43.
   PubMed Web of Science ®Google Scholar
• Schulze-Neick I, Li J, Penny DJ, Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001;121:1033–9.
   PubMed Web of Science ®Google Scholar
• Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999;68:1107–15.
   PubMed Web of Science ®Google Scholar
• Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993;106:473–8.
   PubMed Web of Science ®Google Scholar
• Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11–8.
   PubMed Web of Science ®Google Scholar
• Rahman A, Ustünda B, Burma O, Ozercan IH, Cekirdekçi A, Bayar MK. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass? Eur J Cardiothorac Surg 2000;18:583–8.
   PubMed Web of Science ®Google Scholar
• Later AF, Sitniakowsky LS, van Hilten JA, van de Watering L, Brand A, Smit NP, Klautz RJ. Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery. J Thorac Cardiovasc Surg 2013;145:1611–6.
   PubMed Web of Science ®Google Scholar
• de Vroege R, Huybregts R, van Oeveren W, van Klarenbosch J, Linley G, Mutlu J, Jansen E, Hack E, Eijsman L, Wildevuur C. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. Artif Org 2005;29:490–7.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771–83.
   PubMed Web of Science ®Google Scholar
• Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319–31.
   PubMed Web of Science ®Google Scholar
• Avlonitis VS1, Wigfield CH, Kirby JA, Dark JH. Treatment of the brain-dead lung donor with aprotinin and nitric oxide. J Heart Lung Transplant 2010;29:1177–84.
   PubMed Web of Science ®Google Scholar
• Howell N, Senanayake E, Freemantle N, Pagano D. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. J Thorac Cardiovasc Surg 2013;145:234–40.
   PubMed Web of Science ®Google Scholar